CEST MRI and MALDI imaging reveal metabolic alterations in the cervical lymph nodes of EAE mice

[1]  Andrés J. García,et al.  Localized Hydrogel Delivery of Dendritic Cellsfor Attenuation of Multiple Sclerosis in a Murine Model. , 2020, Journal of biomedical materials research. Part A.

[2]  Aline M. Thomas,et al.  Evaluation of cell transplant-mediated attenuation of diffuse injury in experimental autoimmune encephalomyelitis using onVDMP CEST MRI , 2020, Experimental Neurology.

[3]  L. Boon,et al.  Interleukin-17A Serves a Priming Role in Autoimmunity by Recruiting IL-1β-Producing Myeloid Cells that Promote Pathogenic T Cells. , 2020, Immunity.

[4]  Peter A. Calabresi,et al.  Monitoring diffuse injury during disease progression in experimental autoimmune encephalomyelitis with on resonance variable delay multiple pulse (onVDMP) CEST MRI , 2020, NeuroImage.

[5]  Andrés J. García,et al.  Brief exposure to hyperglycemia activates dendritic cells in vitro and in vivo , 2019, Journal of cellular physiology.

[6]  Aline M. Thomas,et al.  CEST MRI with distribution‐based analysis for assessment of early stage disease activity in a mouse model of multiple sclerosis: An initial study , 2019, NMR in biomedicine.

[7]  M. A. van den Bosch,et al.  Contradiction between amide‐CEST signal and pH in breast cancer explained with metabolic MRI , 2019, NMR in biomedicine.

[8]  G. Riou,et al.  Systemic administration of orexin A ameliorates established experimental autoimmune encephalomyelitis by diminishing neuroinflammation , 2019, Journal of Neuroinflammation.

[9]  S. Saito,et al.  Early detection of elevated lactate levels in a mitochondrial disease model using chemical exchange saturation transfer (CEST) and magnetic resonance spectroscopy (MRS) at 7T-MRI , 2018, Radiological Physics and Technology.

[10]  Paula Ramos Delgado,et al.  Fluorine-19 MRI at 21.1 T: enhanced spin–lattice relaxation of perfluoro-15-crown-5-ether and sensitivity as demonstrated in ex vivo murine neuroinflammation , 2018, Magnetic Resonance Materials in Physics, Biology and Medicine.

[11]  D. L. Thomas,et al.  Quantifying multiple sclerosis pathology in post mortem spinal cord using MRI , 2018, NeuroImage.

[12]  Bailey A. Box,et al.  Glutamate-sensitive imaging and evaluation of cognitive impairment in multiple sclerosis , 2018, Multiple sclerosis.

[13]  M. Manto,et al.  The Effects of Gadolinium-Based Contrast Agents on the Cerebellum: from Basic Research to Neurological Practice and from Pregnancy to Adulthood , 2018, The Cerebellum.

[14]  Jiadi Xu,et al.  CEST, ASL, and magnetization transfer contrast: How similar pulse sequences detect different phenomena , 2018, Magnetic resonance in medicine.

[15]  R. Moresco,et al.  18F-VC701-PET and MRI in the in vivo neuroinflammation assessment of a mouse model of multiple sclerosis , 2018, Journal of Neuroinflammation.

[16]  Bailey A. Box,et al.  Amide proton transfer CEST of the cervical spinal cord in multiple sclerosis patients at 3T , 2018, Magnetic resonance in medicine.

[17]  Mark D. Pagel,et al.  Clinical applications of chemical exchange saturation transfer (CEST) MRI , 2018, Journal of magnetic resonance imaging : JMRI.

[18]  Publisher's Note , 2018, Anaesthesia.

[19]  David H. Miller,et al.  Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria , 2017, The Lancet Neurology.

[20]  J. Ranjeva,et al.  New brain lesions with no impact on physical disability can impact cognition in early multiple sclerosis: A ten-year longitudinal study , 2017, PloS one.

[21]  Caroline Guglielmetti,et al.  Hyperpolarized 13C MR metabolic imaging can detect neuroinflammation in vivo in a multiple sclerosis murine model , 2017, Proceedings of the National Academy of Sciences.

[22]  R. Scott,et al.  Differential methylation at MHC in CD4+ T cells is associated with multiple sclerosis independently of HLA-DRB1 , 2017, Clinical Epigenetics.

[23]  Emily M. Johnson,et al.  Imaging B Cells in a Mouse Model of Multiple Sclerosis Using 64Cu-Rituximab PET , 2017, The Journal of Nuclear Medicine.

[24]  A. Gaultier,et al.  Lineage-Specific Metabolic Properties and Vulnerabilities of T Cells in the Demyelinating Central Nervous System , 2017, The Journal of Immunology.

[25]  Jiadi Xu,et al.  Magnetization Transfer Contrast and Chemical Exchange Saturation Transfer MRI. Features and analysis of the field-dependent saturation spectrum , 2017, NeuroImage.

[26]  Kai Zhang,et al.  Quantitative assessment of the effects of water proton concentration and water T1 changes on amide proton transfer (APT) and nuclear overhauser enhancement (NOE) MRI: The origin of the APT imaging signal in brain tumor , 2017, Magnetic resonance in medicine.

[27]  Richard A. Notebaart,et al.  Glutaminolysis and Fumarate Accumulation Integrate Immunometabolic and Epigenetic Programs in Trained Immunity. , 2016, Cell metabolism.

[28]  Y. Jee,et al.  Blocking glutamate carboxypeptidase II inhibits glutamate excitotoxicity and regulates immune responses in experimental autoimmune encephalomyelitis , 2016, The FEBS journal.

[29]  Benjamin N. Conrad,et al.  Chemical exchange saturation transfer of the cervical spinal cord at 7 T , 2016, NMR in biomedicine.

[30]  B Wu,et al.  An overview of CEST MRI for non-MR physicists , 2016, EJNMMI Physics.

[31]  Penny Gowland,et al.  Comparison of pulsed three‐dimensional CEST acquisition schemes at 7 tesla: steady state versus pseudosteady state , 2016, Magnetic resonance in medicine.

[32]  Menglin Cheng,et al.  CEST‐MRI detects metabolite levels altered by breast cancer cell aggressiveness and chemotherapy response , 2016, NMR in biomedicine.

[33]  O. Khan,et al.  The Relationship Between Brain MR Spectroscopy and Disability in Multiple Sclerosis: 20‐Year Data from the U.S. Glatiramer Acetate Extension Study , 2016, Journal of neuroimaging : official journal of the American Society of Neuroimaging.

[34]  T. Shlomi,et al.  Metabolite concentrations, fluxes, and free energies imply efficient enzyme usage , 2016, Nature chemical biology.

[35]  Ravinder Reddy,et al.  Lactate Chemical Exchange Saturation Transfer (LATEST) Imaging in vivo A Biomarker for LDH Activity , 2016, Scientific Reports.

[36]  H. D. de Vries,et al.  Differential expression of glucose-metabolizing enzymes in multiple sclerosis lesions , 2015, Acta neuropathologica communications.

[37]  Debiao Li,et al.  pH-weighted molecular imaging of gliomas using amine chemical exchange saturation transfer MRI. , 2015, Neuro-oncology.

[38]  P. Magistretti,et al.  Metabolic gene expression changes in astrocytes in Multiple Sclerosis cerebral cortex are indicative of immune-mediated signaling , 2015, Brain, Behavior, and Immunity.

[39]  S. Weed,et al.  High-frequency Ultrasound Imaging of Mouse Cervical Lymph Nodes. , 2015, Journal of visualized experiments : JoVE.

[40]  Sungyoung Auh,et al.  Diffuse and Focal Corticospinal Tract Disease and Its Impact on Patient Disability in Multiple Sclerosis , 2015, Journal of neuroimaging : official journal of the American Society of Neuroimaging.

[41]  Ludwig Kappos,et al.  Correlation between brain volume loss and clinical and MRI outcomes in multiple sclerosis , 2015, Neurology.

[42]  A. Walch,et al.  MALDI Imaging mass spectrometry: current frontiers and perspectives in pathology research and practice , 2015, Laboratory Investigation.

[43]  J. Locasale,et al.  Metabolic programming and PDHK1 control CD4+ T cell subsets and inflammation. , 2015, The Journal of clinical investigation.

[44]  A. Westwell,et al.  A novel radiochemical approach to 1-(2'-deoxy-2'-[(18) F]fluoro-β-d-arabinofuranosyl)cytosine ((18) F-FAC). , 2014, Journal of labelled compounds & radiopharmaceuticals.

[45]  Steven H. Kleinstein,et al.  B cells populating the multiple sclerosis brain mature in the draining cervical lymph nodes , 2014, Science Translational Medicine.

[46]  S. Nelson,et al.  In vivo evidence of glutamate toxicity in multiple sclerosis , 2014, Annals of neurology.

[47]  J. Chao,et al.  IL-17A Induces MIP-1α Expression in Primary Astrocytes via Src/MAPK/PI3K/NF-kB Pathways: Implications for Multiple Sclerosis , 2014, Journal of Neuroimmune Pharmacology.

[48]  L. Pellerin,et al.  Cellular distribution of glucose and monocarboxylate transporters in human brain white matter and multiple sclerosis lesions , 2014, Glia.

[49]  Ravinder Reddy,et al.  Breast Cancer Redox Heterogeneity Detectable with Chemical Exchange Saturation Transfer (CEST) MRI , 2014, Molecular Imaging and Biology.

[50]  Örjan Smedby,et al.  Normal Appearing and Diffusely Abnormal White Matter in Patients with Multiple Sclerosis Assessed with Quantitative MR , 2014, PloS one.

[51]  D. Arnold,et al.  Treatment effect on brain atrophy correlates with treatment effect on disability in multiple sclerosis , 2014, Annals of neurology.

[52]  Xiaolei Song,et al.  Nuts and bolts of chemical exchange saturation transfer MRI , 2013, NMR in biomedicine.

[53]  S. Zorzella-Pezavento,et al.  Persistent Inflammation in the CNS during Chronic EAE Despite Local Absence of IL-17 Production , 2013, Mediators of inflammation.

[54]  E. Pearce,et al.  Metabolic pathways in immune cell activation and quiescence. , 2013, Immunity.

[55]  Örjan Smedby,et al.  Increased Concentrations of Glutamate and Glutamine in Normal-Appearing White Matter of Patients with Multiple Sclerosis and Normal MR Imaging Brain Scans , 2013, PloS one.

[56]  R. Maroy,et al.  Imaging Microglial/Macrophage Activation in Spinal Cords of Experimental Autoimmune Encephalomyelitis Rats by Positron Emission Tomography Using the Mitochondrial 18 kDa Translocator Protein Radioligand [18F]DPA-714 , 2012, The Journal of Neuroscience.

[57]  Bennett A Landman,et al.  Development of chemical exchange saturation transfer at 7T , 2011, Magnetic resonance in medicine.

[58]  John A. Detre,et al.  Magnetic Resonance Imaging of Glutamate , 2011, Nature Medicine.

[59]  A. Rudensky,et al.  Interleukin-10 signaling in regulatory T cells is required for suppression of Th17 cell-mediated inflammation. , 2011, Immunity.

[60]  Nirbhay N. Yadav,et al.  Chemical exchange saturation transfer (CEST): What is in a name and what isn't? , 2011, Magnetic resonance in medicine.

[61]  F. Barkhof,et al.  Genetic Correlations of Brain Lesion Distribution in Multiple Sclerosis: An Exploratory Study , 2011, American Journal of Neuroradiology.

[62]  M. Lynch,et al.  Infiltration of Th1 and Th17 cells and activation of microglia in the CNS during the course of experimental autoimmune encephalomyelitis , 2010, Brain, Behavior, and Immunity.

[63]  R. Hintzen,et al.  Surgical excision of CNS‐draining lymph nodes reduces relapse severity in chronic‐relapsing experimental autoimmune encephalomyelitis , 2009, The Journal of pathology.

[64]  I. Bechmann,et al.  Brain antigens in functionally distinct antigen-presenting cell populations in cervical lymph nodes in MS and EAE , 2009, Journal of Molecular Medicine.

[65]  S. Morrissey,et al.  MRI as an outcome in multiple sclerosis clinical trials , 2009, Neurology.

[66]  J. Honnorat,et al.  Cerebrospinal Fluid Dendritic Cells Infiltrate the Brain Parenchyma and Target the Cervical Lymph Nodes under Neuroinflammatory Conditions , 2008, PloS one.

[67]  K. Bendtzen,et al.  T helper cell type 1 (Th1), Th2 and Th17 responses to myelin basic protein and disease activity in multiple sclerosis , 2008, Immunology.

[68]  R. Mutani,et al.  Altered Glutamate Reuptake in Relapsing-Remitting and Secondary Progressive Multiple Sclerosis Cortex: Correlation With Microglia Infiltration, Demyelination, and Neuronal and Synaptic Damage , 2007, Journal of neuropathology and experimental neurology.

[69]  M. Phelps,et al.  Positron emission tomography with computed tomography imaging of neuroinflammation in experimental autoimmune encephalomyelitis , 2007, Proceedings of the National Academy of Sciences.

[70]  F. Ciruela,et al.  Glutamate Released by Dendritic Cells as a Novel Modulator of T Cell Activation1 , 2006, The Journal of Immunology.

[71]  S. Nakae,et al.  IL-17 Plays an Important Role in the Development of Experimental Autoimmune Encephalomyelitis1 , 2006, The Journal of Immunology.

[72]  T. Grobner.  Gadolinium--a specific trigger for the development of nephrogenic fibrosing dermopathy and nephrogenic systemic fibrosis? , 2006, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[73]  S. Barnum,et al.  Critical Requirement of CD11b (Mac-1) on T Cells and Accessory Cells for Development of Experimental Autoimmune Encephalomyelitis1 , 2005, The Journal of Immunology.

[74]  M. Filippi,et al.  MRI evidence for multiple sclerosis as a diffuse disease of the central nervous system , 2005, Journal of Neurology.

[75]  R. Gold,et al.  Therapeutic efficacy of IL-17 neutralization in murine experimental autoimmune encephalomyelitis. , 2005, Cellular immunology.

[76]  V. Perry,et al.  Detection of the inhibitory neurotransmitter GABA in macrophages by magnetic resonance spectroscopy , 2005, Journal of leukocyte biology.

[77]  Daniel Pelletier,et al.  Evidence of elevated glutamate in multiple sclerosis using magnetic resonance spectroscopy at 3 T. , 2005, Brain : a journal of neurology.

[78]  Changying Ling,et al.  Initiation of Immune Responses in Brain Is Promoted by Local Dendritic Cells1 , 2004, The Journal of Immunology.

[79]  R. Rudick,et al.  Interferon gamma responses to myelin peptides in multiple sclerosis correlate with a new clinical measure of disease progression , 2003, Journal of Neuroimmunology.

[80]  R. Ransohoff,et al.  Human cerebrospinal fluid central memory CD4+ T cells: Evidence for trafficking through choroid plexus and meninges via P-selectin , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[81]  M. Oldstone,et al.  A new approach for evaluating antigen-specific T cell responses to myelin antigens during the course of multiple sclerosis , 2003, Journal of Neuroimmunology.

[82]  D. Pitt,et al.  Multiple sclerosis: Altered glutamate homeostasis in lesions correlates with oligodendrocyte and axonal damage , 2001, Annals of neurology.

[83]  J. Frank,et al.  Encephalitogenic potential of the myelin basic protein peptide (amino acids 83–99) in multiple sclerosis: Results of a phase II clinical trial with an altered peptide ligand , 2000, Nature Medicine.

[84]  S. Khoury,et al.  Kinetics of expression of costimulatory molecules and their ligands in murine relapsing experimental autoimmune encephalomyelitis in vivo. , 1998, Journal of immunology.

[85]  Y. Ron,et al.  Bothanti-CD11a(LFA-l) and anti-CD11b (MAC-1) therapy delay the onset and diminish the severity of experimental autoimmune encephalomyelitis , 1995, Journal of Neuroimmunology.

[86]  T. Traut,et al.  Physiological concentrations of purines and pyrimidines , 1994, Molecular and Cellular Biochemistry.

[87]  M. Cuénod,et al.  Murine brain macrophages induce NMDA receptor mediated neurotoxicity in vitro by secreting glutamate , 1991, Neuroscience Letters.

[88]  W. I. McDonald,et al.  Heterogeneity of blood‐brain barrier changes in multiple sclerosis , 1990, Neurology.

[89]  R. Moresco,et al.  (18)F-VC701-PET and MRI in the in vivo neuroinflammation assessment of a mouse model of multiple sclerosis , 2019 .

[90]  Jia Newcombe,et al.  Interleukin-17 production in central nervous system-infiltrating T cells and glial cells is associated with active disease in multiple sclerosis. , 2008, The American journal of pathology.

[91]  Chantal Wouters,et al.  An exploratory study , 2003 .

[92]  D. Pitt,et al.  Glutamate excitotoxicity in a model of multiple sclerosis , 2000, Nature Medicine.